A Noncompetitive BACE1 Inhibitor TAK-070 Ameliorates Aβ Pathology and Behavioral Deficits in a Mouse Model of Alzheimer's Disease
Hiroaki Fukumoto(Unknown), Masaomi Miyamoto(Io Therapeutics (United States))
Cited by 129
Related Papers
Early Aβ accumulation and progressive synaptic loss, gliosis, and tangle formation in AD brain
|Neurology|2004|655
β-Secretase Activity Increases with Aging in Human, Monkey, and Mouse Brain
|American Journal Of Pathology|2004|292
Demonstration by FRET of BACE interaction with the amyloid precursor protein at the cell surface and in early endosomes
|Journal of Cell Science|2003|286
Age but Not Diagnosis Is the Main Predictor of Plasma Amyloid β-Protein Levels
|Archives of Neurology|2003|257
Expression of APP pathway mRNAs and proteins in Alzheimer’s disease
|Brain Research|2007|187